Publications | Lund University Publications

111 – 120 of 327

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221351-8216%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
11
12
13
14
…
33
next »

2014
Mark Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry
Fischer, K. ; Ljung, Rolf ^LU ; Platokouki, H. ; Liesner, R. ; Claeyssens, S. ; Smink, E. and Van den Berg, H. M. (2014) In Haemophilia 20(4). p.280-286
- Contribution to journal › Article
Mark Similar bleeding phenotype in young children with haemophilia A or B : A cohort study
Clausen, Niels ; Petrini, P. ; Claeyssens-Donadel, S. ; Gouw, S. C. ; Liesner, R. ; Altisent, C. ; Auerswald, G. ; Carcao, M. ; Chalmers, E. and Chambost, H. , et al. (2014) In Haemophilia 20(6). p.747-755
- Contribution to journal › Article
2013
Mark Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)
Abshire, T. C. ; Federici, A. B. ; Alvarez, M. T. ; Bowen, J. ; Carcao, M. D. ; Gill, J. Cox ; Key, N. S. ; Kouides, P. A. ; Kurnik, K. and Lail, A. E. , et al. (2013) In Haemophilia 19(1). p.76-81
- Contribution to journal › Article
Mark Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.
Berntorp, Erik ^LU (2013) In Haemophilia 19(6). p.805-807
- Contribution to journal › Debate/Note/Editorial
Mark Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.
Lövdahl, Susanna ^LU ; Henriksson, Marie ^LU ; Baghaei, F ; Holmström, Eva M ^LU ; Nilsson, J-Å ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2013) In Haemophilia 19(3). p.362-369
- Contribution to journal › Article
Mark Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
Ljung, Rolf ^LU ; Auerswald, G ; Benson, G ; Jetter, A ; Jiménez-Yuste, V ; Lambert, T ; Morfini, M ; Remor, E ; Sørensen, B and Salek, S Z (2013) In Haemophilia 19(4). p.481-486
- Contribution to journal › Scientific review
Mark Progressive improvement in wound healing with increased therapy in haemophilia B mice
Monroe, D. M. ; Hoffman, M. ; Roberts, H. R. and Hedner, Ulla ^LU (2013) In Haemophilia 19(6). p.926-932
- Contribution to journal › Article
Mark Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
Gringeri, A. ; Leissinger, C. ; Cortesi, P. A. ; Jo, H. ; Fusco, F. ; Riva, S. ; Antmen, B. ; Berntorp, Erik ^LU ; Biasoli, C. and Carpenter, S. , et al. (2013) In Haemophilia 19(5). p.736-743
- Contribution to journal › Article
Mark F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Schwarz, J. ; Astermark, Jan ^LU ; Menius, E. D. ; Carrington, M. ; Donfield, S. M. ; Gomperts, E. D. ; Nelson, G. W. ; Oldenburg, J. ; Pavlova, A. and Shapiro, A. D. , et al. (2013) In Haemophilia 19(1). p.113-118
- Contribution to journal › Article
Mark History of prophylaxis.
Berntorp, Erik ^LU (2013) In Haemophilia 19(2). p.163-165
- Contribution to journal › Article

« previous
1
…
11
12
13
14
…
33
next »

your query:: Remove issn: 1351-8216